|
Apoptosis
Citations 21-30 of 746 total displayed.
|
Past content
(since May 2000):
|
Effect of presenilins in the apoptosis of thymocytes and homeostasis of CD8+ T cells
- Antonio Maraver, Carlos E. Tadokoro, Michelle L. Badura, Jie Shen, Manuel Serrano, and Juan J. Lafaille
Blood 2007; 110: 3218-3225.
[Abstract]
[Full text]
[PDF]
Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF- B–regulated gene products
- Kwang Seok Ahn, Gautam Sethi, Ta-Hsiang Chao, Saskia T. C. Neuteboom, Madan M. Chaturvedi, Michael A. Palladino, Anas Younes, and Bharat B. Aggarwal
Blood 2007; 110: 2286-2295.
[Abstract]
[Full text]
[PDF]
Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas
- Christina Spaulding, Erica J. Reschly, Derek E. Zagort, Yumi Yashiro-Ohtani, Levi J. Beverly, Anthony Capobianco, Warren S. Pear, and Barbara L. Kee
Blood 2007; 110: 2650-2658.
[Abstract]
[Full text]
[PDF]
Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils
- Athena Chalaris, Björn Rabe, Krzysztof Paliga, Hans Lange, Tamas Laskay, Ceri A. Fielding, Simon A. Jones, Stefan Rose-John, and Jürgen Scheller
Blood 2007; 110: 1748-1755.
[Abstract]
[Full text]
[PDF]
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
- Jing Yang, Takayuki Ikezoe, Chie Nishioka, Taizo Tasaka, Ayuko Taniguchi, Yoshio Kuwayama, Naoki Komatsu, Kentaro Bandobashi, Kazuto Togitani, H. Phillip Koeffler, Hirokuni Taguchi, and Akihito Yokoyama
Blood 2007; 110: 2034-2040.
[Abstract]
[Full text]
[PDF]
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo
- Min H. Kang, Yun Hee Kang, Barbara Szymanska, Urszula Wilczynska-Kalak, Michael A. Sheard, Theresa M. Harned, Richard B. Lock, and C. Patrick Reynolds
Blood 2007; 110: 2057-2066.
[Abstract]
[Full text]
[PDF]
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms
- Samir Parekh, Jose M. Polo, Rita Shaknovich, Przemyslaw Juszczynski, Paola Lev, Stella M. Ranuncolo, Yingnan Yin, Ulf Klein, Giorgio Cattoretti, Riccardo Dalla Favera, Margaret A. Shipp, and Ari Melnick
Blood 2007; 110: 2067-2074.
[Abstract]
[Full text]
[PDF]
Natural killer cell–derived human granzyme H induces an alternative, caspase-independent cell-death program
- Edward Fellows, Shirley Gil-Parrado, Dieter E. Jenne, and Florian C. Kurschus
Blood 2007; 110: 544-552.
[Abstract]
[Full text]
[PDF]
Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells
- Rudin Kondo, Karoline V. Gleixner, Matthias Mayerhofer, Anja Vales, Alexander Gruze, Puchit Samorapoompichit, Khaled Greish, Maria-Theresa Krauth, Karl J. Aichberger, Winfried F. Pickl, Harald Esterbauer, Christian Sillaber, Hiroshi Maeda, and Peter Valent
Blood 2007; 110: 661-669.
[Abstract]
[Full text]
[PDF]
JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells
- Tanyel Kiziltepe, Teru Hideshima, Kenji Ishitsuka, Enrique M. Ocio, Noopur Raje, Laurence Catley, Chun-Qi Li, Laura J. Trudel, Hiroshi Yasui, Sonia Vallet, Jeffery L. Kutok, Dharminder Chauhan, Constantine S. Mitsiades, Joseph E. Saavedra, Gerald N. Wogan, Larry K. Keefer, Paul J. Shami, and Kenneth C. Anderson
Blood 2007; 110: 709-718.
[Abstract]
[Full text]
[PDF]
|
|
